The allosteric modulation of complement C5 by knob domain peptides

The allosteric modulation of complement C5 by knob domain peptides

DownLoad

Bovines have evolved a subset of antibodies with ultra-long heavy chain complementarity determining regions that harbour cysteine-rich knob domains. To produce high-affinity peptides, we previously isolated autonomous 3-6 kDa knob domains from bovine antibodies. Here, we show that binding of four knob domain peptides elicits a range of effects on the clinically validated drug target complement C5. Allosteric mechanisms predominated, with one peptide selectively inhibiting C5 cleavage by the alternative pathway C5 convertase, revealing a targetable mechanistic difference between the classical and alternative pathway C5 convertases. Taking a hybrid biophysical approach, we present C5-knob domain co-crystal structures and, by solution methods, observed allosteric effects propagating >50 Å from the binding sites. This study expands the therapeutic scope of C5, presents new inhibitors, and introduces knob domains as new, low molecular weight antibody fragments, with therapeutic potential.
Keywords: bovine immunoglobulin; complement C5; human; immunology; inflammation; knob-domain peptides; molecular biophysics; structural biology.

Reference

1. Macpherson, Alex, et al. "The allosteric modulation of complement C5 by knob domain peptides." Elife 10 (2021): e63586. under Open Access license CC BY 4.0, without modification

• Activation of the Complement System on Human Endothelial Cells by Urban Particulate Matter Triggers Inflammation-Related Protein Production
• Adipsin of the Alternative Complement Pathway Is a Potential Predictor for Preeclampsia in Early Pregnancy
• Alternative C3 Complement System: Lipids and Atherosclerosis
• Antimicrobial Peptide Arenicin-1 Derivative Ar-1-(C/A) as Complement System Modulator
• Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder
• C4b Binding Protein Acts as an Innate Immune Effector Against Influenza A Virus
• Coagulation Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis
• Complement Activation in the Central Nervous System: A Biophysical Model for Immune Dysregulation in the Disease State
• Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality
• Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects
• Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology
• Complement Regulation in Human Tenocytes under the Influence of Anaphylatoxin C5a
• Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking
• Inhibition of complement C5a receptor protects lung cells and tissues against lipopolysaccharide-induced injury via blocking pyroptosis
• Interference of the Zika Virus E-Protein With the Membrane Attack Complex of the Complement System
• Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins
• Microglial trogocytosis and the complement system regulate axonal pruning in vivo
• Modulation of complement activation by pentraxin-3 in prostate cancer
• Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab
• Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple Species
• REV-ERBα mediates complement expression and diurnal regulation of microglial synaptic phagocytosis
• SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation
• Specific Evolution and Gene Family Expansion of Complement 3 and Regulatory Factor H in Fish
• Syk facilitates phagosome-lysosome fusion by regulating actin-remodeling in complement-mediated phagocytosis
• The solution structure of the complement deregulator FHR5 reveals a compact dimer and provides new insights into CFHR5 nephropathy
• Two human antibodies to a meningococcal serogroup B vaccine antigen enhance binding of complement Factor H by stabilizing the Factor H binding site